Thermo Fisher Scientific Q2 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28

Reuters

2025/07/23

Thermo Fisher Scientific <a href="https://laohu8.com/S/QTWO">Q2</a> 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28

Thermo Fisher Scientific Inc. has announced its financial results for the second quarter of 2025, showing a 3% increase in revenue, reaching $10.85 billion. The company also reported a 6% rise in GAAP diluted earnings per share $(EPS)$, which amounted to $4.28. The adjusted EPS for the period was $5.36. The company highlighted its strong operational performance, attributing it to the effective management of the macroenvironment and the strength of its PPI Business System. Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific, noted the company's success in navigating current market conditions and maintaining its trusted partner status with customers, which has allowed for market share gains. Thermo Fisher Scientific plans to provide updated financial guidance for 2025 during its earnings conference call. The company is committed to delivering on its 2025 commitments and fostering future growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thermo Fisher Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250722221293) on July 23, 2025, and is solely responsible for the information contained therein.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2553939219"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553939219\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2553939219?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-23 18:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553939219","market":"fut","top_or_hot":-1,"title":"Thermo Fisher Scientific Q2 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Thermo Fisher Scientific <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Thermo Fisher Scientific Inc. has announced its financial results for the second quarter of 2025, showing a 3% increase in revenue, reaching $10.85 billion. The company also reported a 6% rise in GAAP diluted earnings per share <a href=\"https://laohu8.com/S/EPS\">$(EPS)$</a>, which amounted to $4.28. The adjusted EPS for the period was $5.36. The company highlighted its strong operational performance, attributing it to the effective management of the macroenvironment and the strength of its PPI Business System. Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific, noted the company's success in navigating current market conditions and maintaining its trusted partner status with customers, which has allowed for market share gains. Thermo Fisher Scientific plans to provide updated financial guidance for 2025 during its earnings conference call. The company is committed to delivering on its 2025 commitments and fostering future growth.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thermo Fisher Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250722221293) on July 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Thermo Fisher Scientific Q2 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThermo Fisher Scientific Q2 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-23 18:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Thermo Fisher Scientific <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Thermo Fisher Scientific Inc. has announced its financial results for the second quarter of 2025, showing a 3% increase in revenue, reaching $10.85 billion. The company also reported a 6% rise in GAAP diluted earnings per share <a href=\"https://laohu8.com/S/EPS\">$(EPS)$</a>, which amounted to $4.28. The adjusted EPS for the period was $5.36. The company highlighted its strong operational performance, attributing it to the effective management of the macroenvironment and the strength of its PPI Business System. Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific, noted the company's success in navigating current market conditions and maintaining its trusted partner status with customers, which has allowed for market share gains. Thermo Fisher Scientific plans to provide updated financial guidance for 2025 during its earnings conference call. The company is committed to delivering on its 2025 commitments and fostering future growth.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thermo Fisher Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250722221293) on July 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TMO","symbol_name":"赛默飞世尔","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nNDL2Lnv3y:1","article_id":"2553939219","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553939219","pubTimestamp":1753264840,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Thermo Fisher Scientific Inc. has announced its financial results for the second quarter of 2025, showing a 3% increase in revenue, reaching $10.85 billion. The company also reported a 6% rise in GAAP diluted earnings per share , which amounted to $4.28. The adjusted EPS for the period was $5.36. The company highlighted its strong operational performance, attributing it to the effective management of the macroenvironment and the strength of its PPI Business System. Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific, noted the company's success in navigating current market conditions and maintaining its trusted partner status with customers, which has allowed for market share gains. Thermo Fisher Scientific plans to provide updated financial guidance for 2025 during its earnings conference call. The company is committed to delivering on its 2025 commitments and fostering future growth.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TMO":"赛默飞世尔"},"translate_title":"Thermo Fisher Scientific 2025年第二季度：收入增长3%至$10.85 B，GAAP每股收益增长6%至$4.28","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMO":0.9},"content_text":"Thermo Fisher Scientific Q2 2025: Revenue Rises 3% to $10.85B, GAAP EPS Up 6% to $4.28\n    \n\n        Thermo Fisher Scientific Inc. has announced its financial results for the second quarter of 2025, showing a 3% increase in revenue, reaching $10.85 billion. The company also reported a 6% rise in GAAP diluted earnings per share $(EPS)$, which amounted to $4.28. The adjusted EPS for the period was $5.36. The company highlighted its strong operational performance, attributing it to the effective management of the macroenvironment and the strength of its PPI Business System. Marc N. Casper, chairman, president, and CEO of Thermo Fisher Scientific, noted the company's success in navigating current market conditions and maintaining its trusted partner status with customers, which has allowed for market share gains. Thermo Fisher Scientific plans to provide updated financial guidance for 2025 during its earnings conference call. The company is committed to delivering on its 2025 commitments and fostering future growth.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thermo Fisher Scientific Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250722221293) on July 23, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}